Alkem launches affordable semaglutide pre-filled syringes in India

business-standard.com

Alkem Laboratories launched semaglutide pre-filled syringes in India at ₹350, aiming to improve treatment accessibility. The company is the first in India to offer semaglutide in this single-use format, receiving DCGI approval for multiple dosage strengths for diabetes and obesity management. This launch follows Alkem's earlier introduction of injection pens and precedes an upcoming multi-dose vial presentation, offering diverse options for patients and healthcare providers.


With a significance score of 3.1, this news ranks in the top 12% of today's 31321 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Alkem launches affordable semaglutide pre-filled syringes in India | News Minimalist